Anti-Lactate Dehydrogenase B 抗体 [EP1565Y] (ab53292)

ab53292 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab53292 は 6 報の論文で使用されています。

  • Vaughan RA  et al. ß-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer 13:14 (2014). WB ; Human . PubMed: 24460609
  • McCleland ML  et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clin Cancer Res 19:773-84 (2013). WB ; Human . PubMed: 23224736
  • Lichtenfels R  et al. A proteomic view at T cell costimulation. PLoS One 7:e32994 (2012). Flow Cyt ; Human . PubMed: 22539942
  • McCleland ML  et al. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res 72:5812-23 (2012). Immunomicroscopy ; Human . PubMed: 23139210
  • O'Dwyer D  et al. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One 6:e27718 (2011). IHC-Fr ; Human . PubMed: 22125622
  • Liao AC  et al. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma. Pathology 43:707-12 (2011). IHC ; Human . PubMed: 22027740

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"